pranamanam
commited on
Update README.md
Browse files
README.md
CHANGED
@@ -2,7 +2,7 @@
|
|
2 |
license: cc-by-nc-nd-4.0
|
3 |
---
|
4 |
# FusOn-pLM: A Fusion Oncoprotein-Specific Language Model via Focused Probabilistic Masking
|
5 |
-
![image/png](https://cdn-uploads.huggingface.co/production/uploads/64cd5b3f0494187a9e8b7c69/
|
6 |
In this work, we introduce **FusOn-pLM**, a novel pLM that fine-tunes the state-of-the-art [ESM-2-650M](https://huggingface.co/facebook/esm2_t33_650M_UR50D) protein language model (pLM) on fusion oncoprotein sequences, those that drive a large portion of pediatric cancers but are heavily disordered and undruggable. We specifically introduce a novel masked language modeling (MLM) strategy, employing a binding-site probability predictor to focus masking on key amino acid residues, thereby generating more optimal fusion oncoprotein-aware embeddings. Our model improves performance on both fusion oncoprotein-specific benchmarks and disorder prediction tasks in comparison to baseline ESM-2 representations, as well as manually-constructed biophysical embeddings, motivating downstream usage of FusOn-pLM embeddings for therapeutic design tasks targeting these fusions. Please feel free to try out our embeddings and reach out if you have any questions!
|
7 |
|
8 |
|
|
|
2 |
license: cc-by-nc-nd-4.0
|
3 |
---
|
4 |
# FusOn-pLM: A Fusion Oncoprotein-Specific Language Model via Focused Probabilistic Masking
|
5 |
+
![image/png](https://cdn-uploads.huggingface.co/production/uploads/64cd5b3f0494187a9e8b7c69/XLtoAgSNqYDYdTSHEdVqS.png)
|
6 |
In this work, we introduce **FusOn-pLM**, a novel pLM that fine-tunes the state-of-the-art [ESM-2-650M](https://huggingface.co/facebook/esm2_t33_650M_UR50D) protein language model (pLM) on fusion oncoprotein sequences, those that drive a large portion of pediatric cancers but are heavily disordered and undruggable. We specifically introduce a novel masked language modeling (MLM) strategy, employing a binding-site probability predictor to focus masking on key amino acid residues, thereby generating more optimal fusion oncoprotein-aware embeddings. Our model improves performance on both fusion oncoprotein-specific benchmarks and disorder prediction tasks in comparison to baseline ESM-2 representations, as well as manually-constructed biophysical embeddings, motivating downstream usage of FusOn-pLM embeddings for therapeutic design tasks targeting these fusions. Please feel free to try out our embeddings and reach out if you have any questions!
|
7 |
|
8 |
|